Subscribe
Sign In
Tag: CBT > Cannabis DEA
Cannabis Industry Research
The Man Behind DEA’s Federal Marijuana Scam
DEA Senior Policy Adviser Matthew Strait defied presidential mandates for medical research, MMJ International Holdings claims.
January 28, 2025
Top Stories
Former DEA Special Agent Derek S. Maltz Appointed Acting DEA Administrator
The appointee said in May that if science supports cannabis rescheduling ‘then so be it,’ but that it’s ‘crystal clear’ that ‘the Justice Department hijacked the rescheduling process, placing politics above public safety.’
January 21, 2025
Cannabis Rescheduling
DEA Judge Sends Interlocutory Appeal to Administrator; Recommends All Participants Be Included
The judge asked DEA Administrator Anne Milgram to include all designated participants for the cannabis rescheduling hearing to be part of a briefing schedule.
January 16, 2025
Cannabis Rescheduling
Village Farms International Comments on Delayed Cannabis Rescheduling Process
The hearing’s designated participant views the delay as an imperative administrative step and symbolic win for the industry against a ‘conflicted’ DEA.
January 15, 2025
Cannabis Rescheduling
DEA Judge Grants Interlocutory Appeal, Cancels Cannabis Rescheduling Hearing
The rescheduling proceedings won’t pick up for at least 90 days—if at all—pending a resolution of the appeal to the DEA administrator.
January 14, 2025
Cannabis Rescheduling
Interlocutory Appeal Could Derail Cannabis Rescheduling Hearing
New evidence prompted rescheduling advocates’ second effort to oust the DEA from the hearing; if relief is denied, they will seek the appeal.
January 8, 2025
Industry Headlines
Attorney General, DEA Director, Judge Under Federal Court Summons Over DEA Marijuana Policy
Despite the DEA’s policy, MMJ International is moving forward with the FDA on cannabis drug development for Huntington’s disease.
January 6, 2025
Top Stories
Judge Calls DEA Subpoena Request ‘Blunder,’ Rejects 3 of 4 for Cannabis Rescheduling Hearing
Administrative Law Judge John Mulrooney points out the DEA’s error yet provides the agency another shot at subpoenaing three FDA officials.
December 17, 2024
Industry Headlines
Cannabis Bioscience Fights to Include Longtime Patient as Witness in DEA Rescheduling Hearing
As a designated participant, the company filed a petition to allow testimony from Alexis Bortell, who was diagnosed with intractable epilepsy as a child.
December 16, 2024
Industry Headlines
DEA Continues to Block MMJ Marijuana Drug Development for Neurological Disorder
MMJ submitted an FDA Investigational New Drug application for a cannabis-derived medication.
December 11, 2024
Top Stories
Attorney General Undelegated DEA’s Rescheduling Authority, Lawyers Argue; Possible Stay Could Delay Hearings
The cannabis rescheduling buck stops with the DOJ head, according to attorneys arguing that the DEA administrator cannot issue the final rule.
December 5, 2024
Top Stories
DEA Counsel Dodges Question on Support for Cannabis Rescheduling
An administrative law judge asked the agency’s lead attorney the question during preliminary proceedings for an upcoming rescheduling hearing.
December 2, 2024
Page 1 of 8
Next Page